MELISSA PINCKNEY: Open Payments
NPI 1659890465 · ITHACA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$336 in 16 payments from 7 companies in 2025. Trend: 2023 $157 · 2024 $182 · 2025 $336
Food & beverage: $336
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $148 |
| Gilead Sciences, Inc. | 2 | $52 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| ViiV Healthcare Company | 1 | $32 |
| Lilly USA, LLC | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $25 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $14 |
Products named: Ozempic, Rybelsus, PIFELTRO, CABENUVA, MOUNJARO, Wegovy, AIRSUPRA, ILUMYA.
Industry payments across NY — which companies pay providers there.
